Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients.
about
The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and TreatmentNK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Regulation of Natural Killer Cell Function by STAT3Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells.Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15.Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs.Organ-specific phenotypic and functional features of NK cells in humans.TLR/NCR/KIR: Which One to Use and When?Natural killer cells as helper cells in dendritic cell cancer vaccines.Expression and Significance of Th17 and Treg Cells in Pulmonary Infections with Gram-Negative Bacteria.Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade.Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC.Alterations of oncogenes expression in NK cells in patients with cancer.Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.Evolving notions on immune response in colorectal cancer and their implications for biomarker development.Oncogenes in immune cells as potential therapeutic targets.Detecting Disease Specific Pathway Substructures through an Integrated Systems Biology Approach.Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization.Functional activity of natural killer cells in biological fluids in patients with colorectal and ovarian cancers.Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer ImmunotherapiesStem and immune cells in colorectal primary tumour: Number and function of subsets may diagnose metastasis
P2860
Q26745580-777E0B91-5D6F-4DE0-A779-1B163910773CQ26746478-03ABD583-1A13-4882-9750-CEF86DC07214Q26752551-7A7369D6-2BE2-477C-83B9-721ACB4ABF24Q30648415-C1662782-279D-466A-A637-0AB51ED3F811Q35131244-2D56CA50-42FA-49B4-9A3C-247558AD8009Q35149564-0D33C968-A573-4D1E-8748-9B81EF6D3317Q35855391-B4061CB9-1DE7-4381-B5D4-6A6D46E1C7F7Q37323344-8DFF3AA6-74D8-40D2-8357-78565F7A12CCQ37697529-C8518DCE-EFB0-4170-8540-EB84F303D65EQ37726379-D2F567EF-6717-4526-9811-DB1BD5032B29Q38173706-D4C25C41-46EB-4391-A6AA-40A57538CFC9Q38200088-D676E26F-AC72-4DCA-AA57-846BCF056C33Q38352462-605C1841-38D9-43D6-8BFC-DD14107AFBCAQ40066556-A0A3CD8D-B0DB-414F-A50E-AE830FA067BEQ41333332-00EA2889-F27D-43C7-88CF-4A838332E35EQ42279197-C1624227-7C22-4E7B-9C31-29F1BD977EBAQ44717067-4CA0F650-9A00-40DB-B09F-D92D3DBFE377Q50043586-C3B9BACA-B0FD-4CC5-8B07-AF46453C6785Q50098505-90056061-3DBD-4B9B-81AC-C1D7D7DE9CD3Q52716894-A60BBB6A-75FC-4A5A-8BA9-2B1E3C90186BQ54941802-7DDCF6E4-3907-4D96-9DC5-116B2CAE2AA2Q55009499-E1F76435-B646-49BD-850E-8471FFB9BFCFQ55344608-A8C67388-23E0-4671-86C4-07FCE9CA21BCQ57300237-55A0D6B3-70E1-46D3-B407-B7E28B2D320AQ58199154-F81766B0-444C-441D-A678-038D1BAAB009
P2860
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Altered phenotype in periphera ...... om colorectal cancer patients.
@en
Altered phenotype in periphera ...... om colorectal cancer patients.
@nl
type
label
Altered phenotype in periphera ...... om colorectal cancer patients.
@en
Altered phenotype in periphera ...... om colorectal cancer patients.
@nl
prefLabel
Altered phenotype in periphera ...... om colorectal cancer patients.
@en
Altered phenotype in periphera ...... om colorectal cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Altered phenotype in periphera ...... om colorectal cancer patients.
@en
P2093
Alejandro Pairola
Eduardo Huertas
Estrella M Levy
Fernando Sánchez Loria
José Mordoh
Juan M Arriaga
Luisina Bruno
María B Pampena
María P Roberti
Michele Bianchini
P2860
P356
10.1177/1753425912453187
P577
2012-07-10T00:00:00Z